Q-State Biosciences
Sudhir Agrawal D.Phil, FRSC is the Founder and President of ARNAY Sciences since October 2017 and serves as Co-Founder and scientific advisor at Aldebaran Therapeutics while holding the position of Chairman of the Scientific Advisory Board for Genetic Medicines at Alloy Therapeutics, Inc. Additionally, Sudhir Agrawal is a member of several scientific advisory boards, including QurAlis, Dyne Therapeutics, SynGenis, and HAYA Therapeutics SA. Sudhir Agrawal is also a Scientific Advisor at Bolden Therapeutics and an Affiliate and Visiting Professor in the Department of Medicine at UMass Chan Medical School. Sudhir Agrawal completed post-doctoral research in Nucleic Acids at the MRC Laboratory of Molecular Biology, Cambridge, UK, and holds an M.Sc and D.Phil. in Organic Chemistry from Allahabad University, India.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Q-State Biosciences
Q-State Biosciences is a technology-derived medicines company based in Cambridge, MA, that combines advanced human cellular models, unique measurement engineering, and AI/machine learning into a proprietary platform that enables novel discovery of optimized genetically targeted medicines for epilepsy, pain, and other diseases of the CNS.